How much funding has Mirna Therapeutics raised?

Mirna Therapeutics has raised $76.3M in total funding, most recently a Series D round.

When was Mirna Therapeutics founded?

Mirna Therapeutics was founded in 2007.

Where is Mirna Therapeutics headquartered?

Mirna Therapeutics is headquartered in Austin, Texas, United States.

What industry is Mirna Therapeutics in?

Mirna Therapeutics operates in Biotech, Cancer Therapeutics.

How many employees does Mirna Therapeutics have?

Mirna Therapeutics has 11-50 employees.

Mirna Therapeutics

Acquired

Austin, United States · Founded 2007 · $76.3M raised

Biotech

Cancer Therapeutics

Headquarters: Austin, Texas
Employees: 11–50
Founded: 2007
Business Model: B2B

Website: mirnarx.com
Total Funding: $76.3M
Last Round: $41.8M Series DMay 2015
Rounds: 4

About

Mirna Therapeutics was a biopharmaceutical company focused on developing microRNA (miRNA)-directed oncology therapies. Founded in 2007 as a spin-off from Asuragen Inc. in Austin, Texas, Mirna was the first company to advance a microRNA-based therapy into clinical trials for cancer treatment. The company completed an IPO on NASDAQ (ticker: MIRN) in October 2015. In 2017, the company merged with Synlogic, Inc., effectively ending its independent operations.

Summary

Mirna Therapeutics is a Biotech company based in Austin, United States, founded in 2007. It has raised $76.3M in total across 4 rounds, most recently a $41.8M Series D round in May 2015.